Streptomyces roseiscleroticus L827-7 (ATCC53903) produced a novel antifungal and antitumor antibiotic, sultriecin. It exhibited in vitro antifungal activity and potent in vivo antitumor activity against P388 and L1210 leukemias, and B16 melanoma. Sultriecin is composed of several unique structural units; a conjugated triene, an a,/?-unsaturated^-lactone, and a sulfate functionality.
In our continuing search for new microbial metabolites with antitumor activity, Streptomyces roseiscleroticus No. L827-7, isolated from a soil sample of Gujarat State in India, was found to produce a novel antibiotic with potent in vivo activity against P388 and L1210 leukemias, and B16 melanoma. The active principle, sultriecin1'2) was recovered from the fermentation broth with w-butanol extraction and purified by chromatography. Pentalenolactone3'4), aburamycin5)6) and chromomycins7'8) were isolated as co-products from the crude extract. Structural studies by spectroscopic analysis of sultriecin and its desulfated derivative, revealed that sultriecin was 5,6-dihydro-5-hydroxy-6-(6-hydroxy-5-methyl-4-hydroxysulfonyloxyheptadecl ,7,9, l l-tetraenyl)-2/f-pyran-2-one (monosodium salt). In this paper, we describe the production, isolation, physico-chemical properties, structural determination and biological properties of sultriecin. 
Taxonomyof the Producing Organism
Morphology: The aerial mycelium was scantily or not formed on agar media, and when formed, it bore compact or open spiral spore chains (20~50 spores per chain). The spores were oval or oblong (0.6~0.8 x 1.2jwm), and had a smooth surface (Fig. 2) . The substrate mycelium was well branched and not fragmented. In the substrate mycelium, a balloon-like, semi-transparent body (3~10 /mi) with a phorous hypha was numerously born and became a sclerotic globular body (10~30/mi). Scanning electron microscopy showed that the globular surface waved and had no membrane (Fig. 1, A and B) . Thin section micrography indicated the globules envelop irregularly coiled and partially swollen hyphae which were cemented with an extracellular metabolite.
Cultural and physiological characteristics:
The aerial mycelium was not formed on most agar media, but was seen scantily on ISP media Nos. 4 and 7. The reverse color of the substrate mycelium was deep orange to dark reddish brown. Melanin was not produced. Growth occurred between 18°C and 45°C (Tables 1 and 2 ).
Cell chemistry: The amino acids, sugars and phospholipids in the whole cell hydrolysate were analyzed by the methods of Lechevalier9'10). The whole cell hydrolysate was found to contain LL-2,6-diaminopimelic acid and mannose which indicated the cell wall-type I. The phospholipids detected were phosphatidylethanolamine, phosphatidylinositol and phosphatidylglycerol placing the strain in pattern P-II. The hydrolysate of globular bodies contained 2,3-diaminopropionic acid1 1*. Taxonomic position: The globular bodies are identified as a sclerotium which is described in Chainialltl2\
The morphology and cell chemistry revealed that strain L827-7 belongs to the sclerotium-forming species of genus Streptomyces. Its cultural and physiological characteristics (Tables 1 and 2 ) are similar to those of Streptomycesflaviscleroticus12'1 3\ Streptomyces minutiscleroticus12'13\ Streptomyces roseiscleroticus12'13) and Streptomyces ruber12'13).
Physiological comparisons of strain L827-7 with the type strain of these species showed that it is accordant with S. roseiscleroticus Pridham IFO 13363T (ISP 5303T), although the latter forms aerial mycelium and reddish brown pigment more abundantly. Thus, strain L827-7 was identified with Streptomyces roseiscleroticus, and has been deposited with the American Type Culture Collection, Rockville, Maryland under the accession number ATCC53903.
Antibiotic Production
A well grown agar slant of S. roseiscleroticus strain L827-7 was used to inoculate a vegetative medium (100ml in a 500-ml flask) consisting of malt extract (Oriental) 2%, corn steep liquor (Oji Corn Starch Co.) 2%, NaCl 0.5%, K2HPO40.02% and CaCO3 0.2%, the pH being adjusted to 7.0 before sterilization. The medium was incubated at 28°C for 3 days on a rotary shaker (200rpm) and 5ml of the growth was transferred into a 500-ml Erlenmeyer flask containing 100ml of the production medium having the same composition as the vegetative medium.The fermentation was carried out at 28°C for 4 days with shaking on a rotary shaker. The antibiotic production in the fermentation broth was determined by the paper disc-agar diffusion method using Candida albicans A9540 and Cryptococcus neoformans IAM4514 as the test organisms. The fermentation was also carried out in a tank fermenter. A 2-liter portion of the vegetative culture prepared by the flask fermentation was transferred into a 200-liter tank fermenter containing 120 liters of the production medium. Fermentation was run at 28°C with agitation at 250rpm and aeration rate of 120 liters per minute. The antibiotic production reached a maximumof 30/zg/ml after about 70 hours fermentation.
Isolation and Purification Sultriecin was extracted from the fermentation broth with w-butanol and precipitated from the concentrated extract by w-hexane. The crude solid was purified by column chromatography on Diaion HP-20, silica gel, reversed phase silica gel and Sephadex LH-20 using paper disc assay with C. albicans A9540 and TLC (SiO2, rc-BuOH-AcOH-H2O (4: 1 : 1), detection by I2), The detailed purification and isolation procedures are described in the Experimental section.
Physico-chemical Properties
The physico-chemical properties of sultriecin are summarized in Table 3 together with those of its desulfated derivative. Both compoundsare soluble in water, methanol, ethanol and dimethyl sulfoxide, slightly soluble in acetone and ethyl acetate, but practically insoluble in chloroform and w-hexane. They showedpositive response to iodine vapor and sulfuric acid, while they were negative to ninhydrin and anthrone tests. The molecular formula of sultriecin was established as C23H33O8SNa by HRFAB-MS spectrum. The FAB-MSspectrum of the desulfated derivative showed the corresponding gwasz-molecular ions at m/z 413 (M +Na)+ and 429 (M +K)+. The two antibiotics exhibited characteristic UV absorption at 260, 269 and 279nm in methanol which did not shift in acidic and alkaline solution. The IR spectrum of sultriecin is shown in Fig. 3 . The *H NMRspectrum (Table 4) in DMSO-d6 exhibited two methyl, five methylene (including one nonequivalent methylene at S 2. 17 and 2.38), five methine and ten olefinic protons. The 13C NMRspectrum of sultriecin (Table 4) showed 23 carbon signals which were assigned to two methyl, five methylene, five methine, ten sp2 and one carbonyl carbon.
Structural Studies
The UVabsorption maximaof sultriecin (1) indicated the presence of a triene group. Its IR spectrum displayed an a,/?-unsaturated (5-lactone at 1720 cm" 1 and a sulfate absorption at 1260cm" 1. These spectra resemble to those of fostriecin (CI-920)14'15) which has a triene, a pyrone ring and a phosphate ester. However, 1 is clearly different from the latter in the MSand NMRspectra, and in the absence of phosphate ester as shown by negative Hanes reaction. The negative ion FAB-MS of 1 exhibited a fragment ion at m/z 389 (M-SO3Na)", together with the^woM-molecular ion at m/z 491 ((M-H)", C23H32O8SNa)
suggesting the presence of a monosodiumsulfate ester. This was evidenced by the fact that incubation of 1 with a sulfatase (Sigma Chem.) in 0.1 m Tris-HCl buffer (pH 7.5) afforded a desulfated derivative (2, C23H34O5) . The IR and UVspectra of 2 are very similar to those of 1 except for the absence of IR absorption at 1260cm"1 assigned as the sulfate group. The XHNMRspectrum of 1 (Table 4) (1)^^H COSYexperiment and partial structures of sultriecin.
( );<3HinDMSO-J6,*; /inHz. that of 1 except that a methine proton at 3 4.46 (9-H) observed in 1 moved to the up field at S 3.94 in 2, indicating that 2 has a hydroxyl group in place of the sulfate group at C-9 of 1. The low field methine carbon at 5 71.0 in the 13C NMRspectrum (Table 4 ) of 1, was assigned to the carbon (C-9) substituted by a sulfate ester. Acetylation of 1 in pyridine afforded a diacetate (3) which showed down field shift of two oxymethine signals at S 4.09 (4-H) and 4.29 (ll-H) of 1 to S 5.24 and 5.28, respectively, supporting the unit A structure. The remaining structure (Cl !H17, unit B) of 1 was determined as follows. The presence ofa conjugated triene fragment in 1 has been deduced by the UVand NMRspectra (Table 4 ). The additional one methyl and four methylenes (Table 4) were determined to be CH2CH2CH2CH2CH3 by the WHCOSY experiment (Fig. 4-1) . The terminal methylene (18-H2) of this rc-pentyl group exhibited a clear connectivity with a methine proton (16-H, 8 5.74) of the triene moiety establishing unit B structure.
The connection of the units A and B was accomplished by long range 13C-XHCOSYexperiment (Fig.  4-2) . Although proton-proton coupling was not observed between ll-H (S 4.29) and 12-H (S 5.35), ll-H coupled to the terminal sp2 carbon (C-12, 3 135.2) of the triene moiety in the long range 13C-1H COSY. The stereochemistries of the four double bonds in the side chain were established as E (6~7), Z (12~13), Z (14~15), £ (16~17) on the basis of their coupling constants (ll.3Hz for Z, 15.1 Hz for E) assisted by the 1H-1H COSYexperiment. Thus, the total structures of 1 and 2 have been determined as Fig. 5 .
Antifungal Activity In vitro antifungal activity was determined against various fungi by the serial 2-fold agar dilution method using Sabouraud's dextrose agar (pH 7.0). MIC values of 1 and the reference compounds, Table 5 . 1 exhibited moderate and broad spectrum antifungal activity, but it is not active against Aspergillus fumigatus IAM2034 and Sporothrix schenckii IFO 8158. The desulfated derivative 2 lacks antifungal activity. Antitumor Activity Both 1 and 2 inhibited growth of the murine and human tumor cell lines with the IC50 values of 0.85-^37.7/^g/ml and 5.5~14.7//g/ml, respectively (Table 6) . Among six cell lines tested, 1 exhibited the most potent cytotoxic activity against Moser (human colorectal carcinoma) and K562(human myelogenous leukemia) cells. Interestingly, 1 and 2 showed almost the comparable cytotoxicity against the resistant (P388/VCR, A548/VP29 and K562/ADM) and their parent cell lines. The inhibitory effects of 1 and 2 on macromolecule biosynthesis were determined in cultured L1210 murine leukemia cells. As shown in Table  7 , 1 and 2 primarily inhibited RNAand protein synthesis with the IC50 values around 2.4~8.1^g/ml, and did not inhibit DNAsynthesis at lOOjUg/ml.
The in vivo antitumor activity was determined in tumor-bearing mice. 1 demonstrated significant prolongation of the survival time of mice inoculated with P388 (Table 8 ) and B16 melanoma ( Table 9 ). The activity of 1 was comparable to mitomycin C against P388 leukemia but somewhat weaker against B16 melanoma in terms of minimumeffective dose. 2 was devoid of in vivo antitumor activity against P388 leukemia. Sultriecin is a structurally unique antibiotic containing an a,/?-unsaturated (5-lactone, a conjugated triene and a sulfate ester. It is partly related to fostriecin and its analogs14'15) in having an a,/?-unsaturated (3-lactone and a conjugated triene system, but is distinctly different from them in possessing a sulfate group. Phospholine16), phosphazomycins1 7) and phoslactomycin1 8) also contain an a,/?-unsaturated (S-lactone and a phosphate group and were reported to show antifungal and/or antitumor activity.
Fostriecin showed antitumor activities against P388 leukemia but no activity against solid tumors.
Although sultriecin had relatively weak in vitro cytotoxicity, it exhibited good in vivo antitumor activities against P388 leukemia and B16 melanoma. It is interesting to note that the desulfated derivative exhibited in vitro cytotoxicity and inhibition ofmacromolecule biosynthesis comparable to those of sultriecin, but it did not show in vitro antifungal activity and in vivo anti-P388 effect.
Experimental General MP's were determined using a Yanagimotomicro-melting point apparatus and uncorrected. TLCwas performed on precoated silica gel plate (Kieselgel 60F254, Merck.) The IR and UVspectra were recorded on a Jasco IR-810 IR spectrophotometer and a Jasco UVIDEC-610C spectrophotometer, respectively. The XHand 13C NMRspectra were recorded on a Jeol JMN-GX400spectrometer operated in the Fourier transform mode using DMSO-J6(3C 39.5, Sn 2.50) as the internal standard. The FAB-MSspectra were measured on JMS-AX505H mass spectrometer, and the high-resolution FAB-MS(HRFAB-MS) on a VG70SE spectrometer. Optical rotations were determined with a Jasco Model DIP-140.
Isolation and Purification of Sultriecin (1) The fermentation broth (58 liters, pH 7.5) was stirred with rc-BuOH (40 liters) for one hour. The organic layer (30 liters) separated was concentrated in vacuo to one liter which was added dropwise into fl-hexane (10 liters) to deposit a crude solid of the antibiotic complex (32.2g). This was dissolved in 50% aqueous MeOH(2.8 liters) and applied on a column ofDiaion HP:20 (8.0 i.d. x 20cm) which was developed successively with 50% and 80% aqueous MeOHand 80% aqueous Me2CO.The eluate was collected in fractions, and examined by paper disc assay using C. albicans A9540. The combined active fractions were concentrated in vacuo and the concentrate was chromatographed on a silica gel column 4.0 i.d.x70cm) . The eluate was monitored on the basis of the bioassay and TLC(SiO2, «-BuOH-AcOH-H2O, 4: 1 : 1). After elution of co-produced pentalenolactone, aburamycin and chromomycinswith w-hexane -Me2CO(1 : 1), sultriecin was eluted with Me2CO. The appropriate fractions were concentrated and purified on a reversed phase silica gel column (YMC-GEL ODS-60, 4.0 i.d. x 32 cm) using acetonitrile-1/15m phosphate buffer, pH 7.0, (2:8) and then (3 :7). The active fractions were concentrated and desalted by Diaion HP-20 to afford a semi-pure solid of sultriecin (2.2 g). The solid was dissolved in 10% aqueous MeOH(pH 9.0, 100ml) containing EDTA (100mg) and stirred for 3 hours.
The solution was passed through a column of Diaion HP-20, and the adsorbed antibiotic was recovered by MeOHelution. The eluate was concentrated and chromatographed on a column of Sephadex LH-20 (4.0 i.d. x 40cm) with MeOHelution. The fractions containing sultriecin were concentrated in vacuo to yield 753 mg of pure sultriecin as a white amorphous powder.
Enzymatic Hydrolysis of Sultriecin (1) with Sulfatase To a solution of 1 (45mg) in 0.1 MTris-HCl buffer (pH 7.5, 10ml), was added sulfatase (28mg, S-3009 type H-5, Sigma Chemical Co.) and the mixture was incubated at 37°C for 18 hours. The reaction mixture was poured into water (40ml) and extracted with two 50ml portions of EtOAc. The combined extracts were evaporated to dryness in vacuo and the residue was purified by preparative TLC (SiO2, CH2Cl2-MeOH, 5: 1) followed by Sephadex LH-20 chromatography using MeOHas a developing solvent to afford the desulfated sultriecin (2, 8mg Acetylation of 1 1 (20mg) was stirred with acetic anhydride (0.3ml) and pyridine (1.0ml) for 18 hours at room temperature. The solution was diluted with EtOAc (20 ml), and washed successively with dil HC1 (20 ml) and water (20ml). The organic solution was evaporated to a residue which was purified by preparative In Vitro Cytotoxicity and Inhibition of Macromolecule Biosynthesis B16-F10 (murine melanoma) and Moser cells were grown in Eagle's minimumessential medium (Nissui) supplemented with fetal calf serum (FCS, 10%) and kanamycin (60fig/m\), A549 (human lung carcinoma), A549/VP29 (an etoposide-resistant subline of A549), and HCT-1 16 (human colon carcinoma) cells were grown in McCoy's 5A Medium (Gibco) supplemented with FCS (10%), penicillin (lOOu/ml) and streptomycin (100 /ig/ml), and K562 and K562/ADM(an doxorubicin-resistant subline of K562), P388 (murine leukemia) and P388/VCR (a vincristine-resistant subline of P388) were in RPMI 1640 medium supplemented with FCS (10%), penicillin (100 u/ml) and streptomycin (100 /zg/ml) at 37°C under humidified atmosphere in a CO2 incubator. The exponentially growing B16-F10, Moser, A549 (A549/VP29), K562 (K562/ADM), HCT-1 16 and P388 (P388/VCR) cells were harvested, counted and suspended in the culture media at 1.5 x 104, 2.5x 105, 3x 104, 3 x 104, 3 x 104 and 3 x 104cells/ml, respectively. The test materials were planted into the wells of 96-or 24-well tissue culture plate and incubated for 72 hours. The cytotoxic activities were colorimetrically determined at 540 nmafter staining viable cells with neutral red solution.
The inhibition of macromolecule biosynthesis was assessed using L1210 murine leukemia cells. The cells (5 x 105cells/ml) were first incubated with the test materials at 37°C for 15 minutes and after the addition of the labeled precursor, [3H]thymidine, [14C]uridine or [3H]leucine into the cultured mixture, further incubated for 60 minutes. After washing the cells with chilled 5% TCAsolution, the radioactivity incorporated into the acid-insoluble fraction of the tumor cells was determined with a liquid scintillation counter.
In Vivo Antitumor Activity B16 melanoma was intraperitoneally inoculated with 0.5ml of 10% brei per male BDFXmouse, and P388 leukemia intraperitoneally inoculated with 106 cells per female CDFi mouse. The test materials were intraperitoneally administered to the tumor-bearing mice by the following treatment schedules: Once daily ondays 1 to 3 (Q1Dx3), onceadayondays 1, 4and 7(Q3Dx3).
